Stockscreener 앱 받기
1.01
1.94%
-0.02
시간 외 거래:
1.00
-0.01
-0.99%
전일 마감가:
$1.03
열려 있는:
$1.02
하루 거래량:
475.59K
Relative Volume:
1.68
시가총액:
$37.02M
수익:
$928.00K
순이익/손실:
$-11.11M
주가수익비율:
-2.8411
EPS:
-0.3555
순현금흐름:
$-10.40M
1주 성능:
+25.00%
1개월 성능:
+7.39%
6개월 성능:
-24.06%
1년 성능:
+3.70%
1일 변동 폭
$0.9701
$1.05
1주일 범위
$0.81
$1.08
52주 변동 폭
$0.7006
$1.45
Renovorx Inc Stock (RNXT) Company Profile
명칭
Renovorx Inc
전화
408-800-2649
주소
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW
Compare RNXT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RNXT
Renovorx Inc
|
1.01 | 37.75M | 928.00K | -11.11M | -10.40M | -0.3555 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Renovorx Inc 주식(RNXT)의 최신 뉴스
Aug Wrap: Can KLRS outperform under higher oil prices2026 Final Week & Weekly Breakout Watchlists - baoquankhu1.vn
Support Test: Is RenovoRx Inc exposed to political riskEarnings Performance Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
RenovoRx Announces $10 Million at Market Private Placement - Investing News Network
RenovoRx, Inc. announced that it expects to receive $10 million in funding - marketscreener.com
RenovoRx raises $10M in oversubscribed private placement - Investing.com
RenovoRx announces $10 million at market Private Placement - marketscreener.com
Renovorx Announces $10 Million At Market Private Placement - TradingView
$10M investor bet on RenovoRx cancer device and trial push - Stock Titan
Aug Fed Impact: Is RenovoRx Inc a defensive stock2026 Market Mood & Safe Capital Growth Tips - baoquankhu1.vn
RNXT Should I Buy - Intellectia AI
Gains Recap: What hedge funds are buying Arko CorpRate Cut & AI Forecast Swing Trade Picks - baoquankhu1.vn
Returns Recap: Can RenovoRx Inc expand its profit margins2026 Growth vs Value & Accurate Intraday Trade Tips - baoquankhu1.vn
What dividend safety score for RenovoRx Inc. stockEarnings Recap Report & Real-Time Volume Surge Alerts - Naître et grandir
Market Review: How much upside does RenovoRx Inc have2025 Technical Patterns & Growth Focused Entry Reports - baoquankhu1.vn
Insider Buy: Is RenovoRx Inc stock a value trapJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Aug Macro: What chart patterns are forming on RenovoRx IncRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Block Trades: Will RenovoRx Inc benefit from rate cuts2025 Biggest Moves & Precise Trade Entry Recommendations - baoquankhu1.vn
Guidance Update: Is RenovoRx Inc stock overvalued or fairly pricedJuly 2025 Recap & AI Driven Price Predictions - baoquankhu1.vn
RenovoRx Advancing RenovoCath Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum - marketscreener.com
US Market Recap: Whats the outlook for RenovoRx Incs sectorM&A Rumor & AI Enhanced Trading Alerts - baoquankhu1.vn
RenovoRx, Inc. (NASDAQ:RNXT) Short Interest Down 20.6% in February - Defense World
RenovoRx advances RenovoCath adoption at U.S. cancer centers - Yahoo Finance
RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum - Investing News Network
After 700 cancer procedures, RenovoCath gets new doctor-led commercial push - Stock Titan
Targeted chemo delivery for pancreatic cancer to feature at 2026 SIR meeting - Stock Titan
RNXT PE Ratio & Valuation, Is RNXT Overvalued - Intellectia AI
RenovoRx (RNXT) Price Target Increased by 10.66% to 6.88 - Nasdaq
Hedge Fund Bets: Will eBay Inc Preferred Security stock hit new highs in YEAR2025 Bull vs Bear & Long-Term Capital Growth Strategies - baoquankhu1.vn
Is RenovoRx Inc. stock overvalued or fairly pricedSwing Trade & Daily Technical Forecast Reports - mfd.ru
Dow Update: How much upside does RenovoRx Inc haveJuly 2025 Market Mood & Weekly Top Stock Performers List - baoquankhu1.vn
RenovoRx (NASDAQ:RNXT) vs. MetaVia (NASDAQ:MTVA) Head-To-Head Survey - Defense World
Mark Voll Joins RenovoRx as Chief Financial Officer - Medical Product Outsourcing
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Labcorp Holdings (LH), Medtronic (MDT) and RenovoRx (RNXT) - The Globe and Mail
RenovoRx (NASDAQ:RNXT) Price Target Raised to $13.00 at Ascendiant Capital Markets - Defense World
RenovoRx (RNXT): Analyst Raises Price Target Following Positive Outlook | RNXT Stock News - GuruFocus
Micron To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Tuesday - Sahm
Why RenovoRx Inc. stock remains resilientTrade Performance Summary & Safe Entry Point Alerts - mfd.ru
Is RenovoRx Inc. a top pick in the sector2025 Biggest Moves & Growth Focused Entry Point Reports - mfd.ru
Can RenovoRx Inc. deliver consistent EPS growthJuly 2025 Trends & Expert Approved Trade Ideas - mfd.ru
RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results - MSN
Bank Watch: Can RenovoRx Inc deliver consistent EPS growth2025 Market Outlook & Fast Moving Stock Trade Plans - baoquankhu1.vn
Aug Catalysts: What drives XYZGs stock price2025 EndofYear Setup & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
What’s the beta of RenovoRx Inc. stockJuly 2025 Snapshot & Accurate Buy Signal Notifications - mfd.ru
RenovoRx formation of RenovoCath Medical Advisory Board to support clinical and strategic initiatives - marketscreener.com
RenovoRx Forms Medical Advisory Board to Support RenovoCath - Intellectia AI
RenovoRx Establishes RenovoCath® Medical Advisory Board - Investing News Network
Renovorx Formation Of Renovocath Medical Advisory Board To Support Clinical And Strategic Initiatives - TradingView
RenovoRx, Inc. Establishes Medical Advisory Board to Advance RenovoCath Clinical Initiatives and Targeted Oncology Therapies - Quiver Quantitative
RenovoRx, Inc. Establishes RenovoCath Medical Advisory Board - marketscreener.com
Top radiologists join new board to shape targeted cancer drug delivery - Stock Titan
Renovorx Inc (RNXT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):